PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 16 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VANGUARD GROUP INC | 154,536 | $57,487 | 0.00% |
UBS Group AG | 23,029 | $8,521 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 22,398 | $8,332 | 0.00% |
Cetera Investment Advisers | 75,000 | $27,900 | 0.00% |
WELLS FARGO & COMPANY/MN | 93 | $35 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 106,917 | $39 | 0.00% |
MORGAN STANLEY | 1,500 | $558 | 0.00% |
BlackRock Inc. | 19 | $7 | 0.00% |
TWO SIGMA SECURITIES, LLC | 19,707 | $7,331 | 0.00% |